Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 F

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Ukraine , Canada , Toronto , Ontario , United States , America , Canadian , Klaus Paulini , Macimorelin Macrilen , Jenene Thomas , Lou Gehrig , Nasdaq , Aeterna Zentaris , Toronto Stock Exchange , Aeterna Zentaris Inc , European Commission , Ceapro Inc , Exchange Commission , European Union , Zentaris Reports Fourth Quarter , Full Year , Announces Completion , Ongoing Pivotal , Childhood Onset Growth Hormone , Childhood Onset Growth Hormone Deficiency , Canada Business Corporations Act , Chief Executive Officer , Top Line Data , Fourth Quarter , Novo Nordisk Healthcare , Financial Statements , Financial Condition , European Economic Area , Litigation Reform Act , Annual Report , Registration Statement , United States Securities Act ,